Holen Sie sich die Stockscreener-App
0.3995
7.42%
0.0276
Vorhandelsmarkt:
.42
0.0205
+5.13%
Schlusskurs vom Vortag:
$0.3719
Offen:
$0.3899
24-Stunden-Volumen:
797.54K
Relative Volume:
1.59
Marktkapitalisierung:
$24.13M
Einnahmen:
$2.29M
Nettoeinkommen (Verlust:
$-18.63M
KGV:
-0.711
EPS:
-0.5619
Netto-Cashflow:
$-19.32M
1W Leistung:
+7.10%
1M Leistung:
-9.04%
6M Leistung:
-52.16%
1J Leistung:
-66.14%
1-Tages-Spanne:
$0.3801
$0.4073
1-Wochen-Bereich:
$0.3501
$0.4073
52-Wochen-Spanne:
$0.3067
$1.22
Femasys Inc Stock (FEMY) Company Profile
Firmenname
Femasys Inc
Sektor
Telefon
770-500-3910
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.3995 | 24.13M | 2.29M | -18.63M | -19.32M | -0.5619 |
ISRG
Intuitive Surgical Inc
|
451.38 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | Laidlaw | Buy |
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Femasys pushes fertility treatment into OB/GYN offices with first paid use - Stock Titan
Femasys Enables OB/GYNs to Deliver First-Line Fertility - GlobeNewswire
Femasys Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
FEMY Earnings History & Surprises | EPS & Revenue Results | FEMASYS INC (NASDAQ:FEMY) - ChartMill
Femasys Shareholders Approve Reverse Split and Financing Plans - The Globe and Mail
Femasys Inc. (NASDAQ: FEMY) sets 2026 meeting, director and auditor votes - Stock Titan
Femasys (NASDAQ: FEMY) wins approval for reverse split, high-dilution notes - Stock Titan
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up - MSN
FEMY Stock Price, Quote & Chart | FEMASYS INC (NASDAQ:FEMY) - ChartMill
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026 - The Manila Times
Femasys (FEMY) Stock Jumps on Deal (+0.71%) 2026-04-18Community Watchlist - UBND thành phố Hải Phòng
Femasys partners with AMI Technologies for Israel market entry By Investing.com - Investing.com India
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio - Sahm
Femasys (FEMY) Forms Partnership with AMI Technologies to Expand Fertility Portfolio - GuruFocus
Femasys partners with AMI Technologies for Israel market entry - Investing.com
Weekly Trades: Is Femasys Inc stock undervalued right now2026 Review & AI Enhanced Execution Alerts - baoquankhu1.vn
Is Femasys (FEMY) Stock Breaking Out | Price at $0.40, Up 0.76%Elite Trading Signals - UBND thành phố Hải Phòng
Femasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share Sale - MSN
Market Rankings: Can Femasys Inc sustain its profitabilityBond Market & Fast Moving Stock Trade Plans - baoquankhu1.vn
What is market pressure on Femasys (FEMY) Stock | Price at $0.39, Down 1.32%Community Chart Signals - Xã Thanh Hà
Femasys (NASDAQ: FEMY) targets reverse split and dilutive note, warrant share issuances - Stock Titan
Can Femasys Inc grow without external funding2026 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
Femasys appoints John Canning as COO - MSN
Femasys Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Lake Street Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Femasys names John Canning as chief operating officer By Investing.com - Investing.com South Africa
Femasys Names John Canning as New Chief Operating Officer - The Globe and Mail
FEMY SEC FilingsFEMASYS INC 10-K, 10-Q, 8-K Forms - Stock Titan
FEMASYS (FEMY) COO awarded 150,000 stock options at $0.38 exercise price - Stock Titan
Femasys (FEMY) COO John Canning discloses ownership of 30,000 shares - Stock Titan
Femasys Inc. Appoints John Canning as Chief Operating Officer, Effective March 30, 2026 - marketscreener.com
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth - bitget.com
Femasys names John Canning as chief operating officer - Investing.com
Femasys names John Canning as Chief Operating Officer - TradingView
Veteran MedTech leader John Canning joins Femasys (NASDAQ: FEMY) as COO - Stock Titan
Femasys earnings beat by $0.12, revenue fell short of estimates - ca.investing.com
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update - National Today
Femasys 2025 10-K: Revenue $2.29M, Net loss per share $(0.47) - TradingView — Track All Markets
Femasys (NASDAQ: FEMY) advances FemBloc and FemaSeed women’s health platform - Stock Titan
Femasys Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Femasys 2025 sales jump on FemBloc demand - TradingView — Track All Markets
Femasys (NASDAQ: FEMY) details 2025 results and FemBloc FINALE trial - Stock Titan
John Charles Canning Net Worth (2026) - GuruFocus
FEMY Should I Buy - Intellectia AI
Femasys (FEMY) price target decreased by 17.74% to 4.34 - MSN
Femasys (FEMY) CFO receives 34,122 Series D-1 warrants at $0.58 - Stock Titan
Femasys (NASDAQ: FEMY) director awarded 34,122 Series D-1 warrants - Stock Titan
Board seeks reverse split, Nasdaq‑rule approval for issuances (FEMY) - Stock Titan
Finanzdaten der Femasys Inc-Aktie (FEMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):